Kyle Faget Authors Article on ‘Compliance Considerations for Entities Providing Hybrid Clinical Trial Services’
April 28, 2022
Journal of Health Care Compliance
Foley & Lardner LLP Partner Kyle Faget authored the article, “Compliance Considerations for Entities Providing Hybrid Clinical Trial Services,” for the March-April 2022 issue of the Journal of Health Care Compliance. In the article, she discusses how clinical trials are leveraging telehealth, the new business model of hybrid clinical trial services, and compliance considerations that should be addressed to enter the market safely.
People
Related News
January 13, 2026
In the News
Louis Lehot Co-Authors 2026 M&A Technology Playbook
Foley & Lardner LLP Louis Lehot co-authored The Legal Intelligencer article, “State of Tech M&A: A 2026 Playbook for Founders Who Want to Win,” providing a practical guide for founders of emerging companies considering mergers and acquisitions.
January 6, 2026
In the News
Kyle Faget Weighs in on Pharmaceutical Industry Legal Battles
Foley & Lardner LLP partner Kyle Faget shared insight with Law360 on major legal topics affecting the pharmaceutical industry.
January 2, 2026
In the News
Judith Waltz Shares Insights on Key Health Law Developments on AHLA Podcast
Foley & Lardner LLP partner Judith Waltz hosted the American Health Law Association's Speaking of Health Law podcast to discuss major health law developments from 2025 and offer insights on trends expected in 2026.